| abstract |
In its many embodiments, the present invention provides a novel class of imidazopyrazine compounds of formula (I) (see formula (I)) as inhibitors of protein kinases and / or control point kinases, methods for preparing said compounds, pharmaceutical compositions which include one or more of said compounds, methods for preparing pharmaceutical formulations that include one or more of said compounds, and methods for the treatment, prevention, inhibition, or improvement of one or more diseases associated with the protein kinases or kinases of the point of control using said compounds or pharmaceutical compositions. |